IGIbrahim Gulseren

Ibrahim Gulseren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ibrahim Gulseren has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ultrafiltration duration dependence of in vitro bioactive attributes in sunflower protein hydrolysates

    by Güneş, Zeynep Saliha, Bilal Çakır, Sena Nur Duman, İbrahim Gülseren


  • Open Access

    Nanoliposomal Encapsulation and Purification of Angiotensin-Converting Enzyme Inhibitor Peptides from Ulva rigida

    by Eda Şensu, Harun Koku, Evren Demircan, Sebahat Şişman, İbRahim Gülseren, Tuğçe Karaduman, Bilal Çakır, Emine Şükran Okudan, Gökhan Duruksu, Beraat Özçelik, et al.

    Angiotensin-converting enzyme inhibitory peptides derived from natural sources may be effective in the treatment of hypertension without causing side effects compared with existing angiotensin-converting enzyme (ACE) inhibitors. Naturally derived antihypertensive peptides are therefore considered a promising alternative for the prevention or treatment of hypertension. Therefore, the study aimed to purify and identify ACE-inhibitory peptides from the green macroalgae Ulva rigida. In addition, the encapsulation of the purified peptides showed the highest ACE-inhibitory activity by chitosan-coated nanoliposomes, and the characterization of nanoliposomes was evaluated. Protein hydrolysates were obtained from U. rigida through enzymatic hydrolysis. The hydrolysates were separated into molecular weights of <3, <5, and <10 kDa through ultrafiltration membrane separation (UFMS). The <3 kDa fraction (UFMS-3) that exhibited the highest ACE-inhibitory activity (77.02%, 1 mg/mL) was purified using ion-exchange chromatography. Fraction-1 (IEC-F1) obtained from the ion-exchange purification showed an impressive 82.03% ACE-inhibitory activity. Moreover, peptide sequences of IEC-F1 were identified by LC-MS/MS, and their bioactive properties were determined in silico. After that, IEC-F1, with a strong ACE-inhibitory activity, was loaded into chitosan-coated nanoliposomes to improve their stability for encapsulation. Physical stability (ζ-potential, polydispersity index, particle size), thermal (DSC) and morphological properties (SEM), and FT-IR analyses were carried out for the characterization of nanoliposomes. Encapsulation efficiency was found to be 92.0 ± 4.5%. After encapsulation, the ACE-inhibitory activity of IEC-F1 was protected by 37.5%. Overall, the obtained findings indicate that the hydrolysate produced by the successive hydrolysis of U. rigida macroalgae with pepsin and trypsin contains peptides with strong ACE-inhibitory action. Furthermore, the chitosan-coated nanoliposome method was determined to be an effective carrier for the delivery of peptide fractions, showing ACE-inhibitory activity. The formulation of chitosan-coated nanoliposomes for peptide fractions from U. rigida represents an innovative approach that allows the development of functional and stable products.


  • The influence of pectinase treatments on the characteristics of pre-treated and lyophilised sunflower meal-whey blends

    by Zeynep Saliha Güneş, Norbert Raak, Milena Corredig, İbRahim Gülseren

    Whey and sunflower meals are primary by-products of dairy cheese and vegetable oil production, respectively. Due to their widespread abundance, their valorisation could enable the generation of various value-added food ingredients or products. In this study, an effort was made to utilise enzymatic pectinolysis along with other pre-treatments to generate mixtures from whey and sunflower meal (SFM). The increasing presence of SFM increased the critical denaturation temperature of the mixtures and induced less protein structural changes. In addition, the presence of complex carbohydrates in SFM enhanced water and oil holding capacities. In general, pectinase and ultrasonication led to enhanced foaming of the mixtures, although the foams were relatively short-lived. SFM inclusion limited foaming and emulsification capacities of the blends. In most cases, increasing the ratio of SFM to protein resulted in lower total reducing sugars (TRS), suggesting a more limited enzymatic activity. On the other hand, heating temperature or ultrasonication improved the extent of pectinolysis. Pre-treatments and pectinolysis improved the functional properties of SFM and whey protein concentrate blends and are promising as an alternative protein source in new product applications.


  • Open Access

    Bioactive, textural and sensory attributes of soft confections enriched with plant protein hydrolysates

    by Zeynep Saliha Güneş, Sebahat Şişman, Özlem Özarda, İbRahim Gülseren

    Soft confections can serve as a reservoir for bioactive peptide delivery in both functional food and food supplement applications. In this study, pectin-based soft confections were fortified with proteolytic plant protein hydrolysates and the residual bioactivity of hydrolysates was studied after processing or simulated digestion. Cold press sunflower or hazelnut cakes were used in the manufacture of protein isolates based on an alkali extraction-isoelectric precipitation (AE-IP) method. Trypsin or bromelain were utilized in the proteolysis of the isolates and thus prepared liquid hydrolysates were used in confectionery manufacture. DPP-IV (dipeptidyl peptidase-IV) inhibitory activity (i.e., in vitro antidiabetic activity) and antioxidative activities were measured. In addition, sensory and textural attributes were investigated. In all cases, a significant concentration of hydrolysates were added to the confections (27%), which lead to significant changes in color, texture and sensory acceptance. The peptide profile and size distribution mostly altered such characteristics, while observed bioactivity was significant after processing. Simulated digestion enhanced DPP-IV inhibitory activity up to approx. 40%, whereas antioxidative performance decreased. While the applicability of the current findings is limited by hydrolysate solubility, ingredient interactions, and processing costs, the relevance of degree of hydrolysis (DH%), peptide characteristics and phenolic-peptide interactions on product quality and eventual bioactivity are being discussed.


  • Open Access

    Fractionation and characterization of heat‐stable basil seed protein isolates and their utilization in high protein gluten‐free bread

    by Mohammad Rashid, İbRahim Gülseren

    Basil ( Ocimum basilicum L.) is an annual plant known for its essential oil and phenolic content. The aim of this study was to isolate and characterize proteins from basil seeds and evaluate their potential in food fortification. The mucilage was removed from the seed by aqueous extraction and thermal hydration, whereas oil was removed via cold pressing. Basil seed protein isolate (BSPI) was obtained by an alkali extraction‐isoelectric precipitation method and contained approximately 95% protein. Once BSPI was fractionated, the samples were characterized by albumin (13.5%), globulin (16.7%), glutelin (39.5%), and prolamin (30.2%) fractions. The denaturation temperature of BSPI and its fractions ranged between 93 and 142°C. Through the analysis of Fourier transform infrared spectra, β‐sheet and β‐turn elements were found to be dominant secondary structures accounting for 89.4% in BSPI, which in turn lead to enhanced thermal stability. Since aqueous dispersibility and water holding capacity (WHC) values were acceptable, BSPI was further utilized in the manufacture of gluten‐free bread. The textural parameters of bread supplemented with 2%, or 10% basil seed protein were mostly comparable to the controls rendering basil protein fortification possible in a staple food, especially for countries where basil is produced in high quantities and is reasonably affordable.


  • In silico prediction of preventive activities of bioactive hazelnut peptides against COVID‐19 and Monkeypox 2022

    by Zeynep Saliha Güneş, Bilal Çakır, İbRahim Gülseren

    The coronavirus 2 (SARS‐CoV‐2), a positive‐sense RNA virus that causes severe acute respiratory illness, is the cause of Coronavirus Disease 2019 (COVID‐19) and Monkeypox is a zoonotic viral disease caused by a double‐strand enveloped DNA virus, a member of the Poxviridae family under the umbrella of the Orthopoxvirus genus. These viruses have harmed global health, societal stability, and global economy prompting the development of new therapeutic options. The purpose of this study was to analyze the potency of hazelnut‐derived bioactive peptides for usage in preventive measures against SARS‐CoV‐2 and Monkeypox infections. Since SARS‐CoV‐2 entry into the host cell takes place through angiotensin‐converting enzyme (ACE) receptors, an in silico attempt was made here to analyze the previously characterized ACE‐inhibitory hazelnut peptides for their anti‐COVID potential. First of all, peptide sequences with PeptideRanker values >0.5 were determined, where 43 of 256 hazelnut peptides met this condition. BIOPEP tools were used to calculate their ACE‐inhibitory characteristics. VPHW and DENPRHF demonstrated the strongest ACE‐inhibitory activity based on BIOPEP analysis. The binding potentials of VPHW (p < 0.001) and DENPRHF (p < 0.001) peptides to ACE were statistically significant based on PepSite2 analysis. The hazelnut‐derived peptides were docked with ACE, spike proteins, SARS‐CoV‐2 proteases, host cell receptors, and Monkeypox 2022 membrane proteins using HPEPDOCK and CABS‐dock. The in silico findings pointed out potential inhibition of SARS‐CoV‐2 main protease in the host cell and Monkeypox 2022 membrane protein and demonstration of multiple bioactivities.


  • Sequence alterations affect the antidiabetic attributes of hazelnut peptide fractions during the industrial manufacture and simulated digestion of hazelnut paste

    by Ayşe Gülden Göksu, Bilal Çakır, İbrahim Gülseren

    Press cakes are by-products of cold press oil manufacture and are characterized by significant protein concentrations. Our group has previously demonstrated potential bioactive attributes of hazelnut protein hydrolysates including their antidiabetic activities. Here, an effort was made to utilize DPP-IV (Dipeptidyl peptidase-IV)-inhibitory hazelnut peptides in industrial food manufacture. Hazelnut protein isolates (approx. 95% protein) were obtained via an alkali extraction-isoelectric precipitation method. Papain, bromelain and pepsin were used in the enzymatic hydrolysis and hydrolysates were fractionated via Fast Protein Liquid Chromatography. As a general observation, although fractionation lead to dilution of the samples, fractions were observed to be more bioactive than the total hydrolysates. In vitro antidiabetic activities of the fractions were tested and 3 antidiabetic fractions were added to hazelnut paste. Afterwards simulated gastrointestinal digestion and antidiabetic activity assays were performed. DPP-IV inhibition was the major antidiabetic mechanism in the fractions and digested paste, while some fractions were characterized by comparable IC50 values as the positive controls. Alpha-glucosidase inhibition was limited by digestion trials, whereas alpha-amylase inhibition was only slight in the digested paste (< %6). In silico analyses predicted partial degradation of the peptides, whereas the interactions between DPP-IV or alpha-glucosidase and hazelnut peptides were predicted to be significant (p < 0.05). Consequently hazelnut press cakes were regarded as a potential source of antidiabetic peptides that can be used in industrial manufacture of functional foods, while food processing conditions or gastrointestinal digestion could largely affect peptide bioactivity.